Parkinsonism

Principles and Practice of Sleep Medicine

Volumn , Issue , 2005, Pages 801-810

  Trenkwalder, Claudia ^a,b  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b Specialized Movement Disorders Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38949212044     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B0-72-160797-7/50074-4     Document Type: Chapter

References (89)

1. Gibb WR, Lees AJ The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51:745-752.
2. Wenning GK, Ben-Shlomo Y, Hughes A, et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?. J Neurol Neurosurg Psychiatry 2000, 68:434-440.
3. Braak H, Rüb U, Gai WP, Del Tredici K Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 2003, 110:517-536.
4. Del Tredici K, Rüb U, De Vos RA, et al. Where does Parkinson's disease pathology begin in the brain?. Neuropathol Exp Neurol 2002, 61:413-426.
5. Parkinson J Essay on the Shaking Palsy 1817, 17. Neely, and Jones, London, Sherwood.
6. Charcot JM Lectures on the diseases of the nervous system [trans. by G. Siegerson] 1877, 147. The New Sydenham Society, Lecture V, London.
7. Forno LS Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 1996, 55:259-272.
8. Langston JW, Forno LS, Rebert CS, et al. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 1984, 292:390-394.
9. Burns RS, Chiueh CC, Markey SP, et al. A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methy 1-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A 1983, 80:4546-4550.
10. Jellinger K Pathology of parkinsonism. Recent Developments in Parkinson's Disease 1986, 33-66. Raven Press, New York. S. Fahn, C.D. Marsden, P. Jenner (Eds.).
11. Zweig RM, Jankel WR, Hedreen JC, et al. The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 1989, 26:41-46.
12. Javoy-Agid F, Agid Y Is the mesocortical dopaminergic system involved in Parkinson's disease?. Neurology 1980, 30:1326-1330.
13. De Keyser J, Ebinger G, Vauquelin G Evidence for a widespread dopaminergic innervation of the human cerebral neocortex. Neurosci Lett 1989, 104:281-285.
14. Ongini E, Caporali MG, Massotti M Stimulation of dopamine-D-1 receptors by SKF 38393 induces EEG desynchronization and behavioural arousal. Life Sci 1985, 37:2327-2333.
15. Bo P, Ongini E, Giorgetti A, et al. Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors. Neuropharmacology 1988, 27:799.
16. Chianchetti C Dopamine agonists and sleep in man. Sleep: Neurotransmitters and Neuromodulators 1985, 121-134. Raven Press, New York. A. Wauquier, J.M. Gaillard, J.M. Monti (Eds.).
17. Bagetta G, De Sarro G, Priolo E, et al. Ventral tegmental area site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Br J Pharmacol 1988, 95:860-866.
18. Svensson K, Alfoldi P, Hajos M, et al. Dopamine autoreceptor antagonists: Effects of sleep-wake activity in the rat. Pharmacol Biochem Behav 1987, 26:123-129.
19. Trampus M, Ferri N, Monopoli A, et al. The dopamine D1 receptor is involved in the regulation of REM sleep in the rat. Eur J Pharmacol 1991, 194:189-194.
20. de Rijik MC, Tzourio C, Breteler MM, et al. Prevalence of parkinsonism and Parkinson's disease in Europe: The Europarkinson Collaborative Study: European Community Concerted Action on the Epidemiology of Parkinson's Disease. J Neurol Neurosurg Psychiatry 1997, 62:10-15.
21. Trenkwalder C, Schwarz J, Gebhard J, et al. Starnberg Trial on Epidemiology of Parkinsonism and Hypertension in the Elderly: Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol 1995, 52:1017-1022.
22. Factor SA, McAlarney T, Sanchez-Ramon JR, et al. Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 1990, 4:280-285.
23. Menza MA, Rosen RC Sleep in Parkinson's disease: The role of depression and anxiety. Psychosomatics 1995, 36:262-266.
24. Comella CL, Tanner CM, Ristanovic RK Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993, 34:710-714.
25. Kales A, Ansel RD, Markham CH, et al. Sleep in patients with Parkinson's disease and normal subjects prior to and following levodopa administration. Clin Pharmacol Ther 1971, 12:397-406.
26. Bergonzi P, Chiurulla C, Gambi D, et al. L-Dopa plus dopadecarboxylase inhibitor: Sleep organization in Parkinson's syndrome before and after treatment. Acta Neurol Belg 1975, 75:5-10.
27. Wetter TC, Collado-Seidel V, Pollmächer T, et al. Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep 2000, 23:361-367.
28. Friedman A Sleep pattern in Parkinson's disease. Acta Med Pol 1980, 21:193-199.
29. Mouret J Differences in sleep in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol 1975, 38:653-657.
30. Brunner H, Wetter TC, Hogl B, et al. Microstructure of the nonrapid eye movement sleep electroencephalogram in patients with newly diagnosed Parkinson's disease: Effects of dopaminergic treatment. Mov Disord 2002, 17:928-933.
31. Plazzi G, Corsini R, Provini F, et al. REM sleep behaviour disorder in multiple system atrophy. Neurology 1997, 48:1094-1097.
32. Aldrich MS, Foster NL, White RF, et al. Sleep abnormalities in progressive supranuclear palsy. Ann Neurol 1989, 25:577-581.
33. Martinelli P, Coccagna G, Rizzuto N, et al. Changes in systemic arterial pressure during sleep in Shy-Drager syndrome. Sleep 1981, 4:139-146.
34. April RS Observations on parkinsonian tremor in all-night sleep. Neurology 1966, 16:720-724.
35. Stern M, Roffwarg H, Duvoisin R The parkinsonian tremor in sleep. J Nerv Ment Dis 1968, 147:202-210.
36. Fish DR, Sawyers D, Allen PJ, et al. The effect of sleep on the dyskinetic movements of Parkinson's disease, Gilles de la Tourette syndrome, Huntington's disease, and torsion dystonia. Arch Neurol 1991, 48:210-214.
37. Ondo WG, Vuong KD, Jankovic J Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002, 59:421-424.
38. Lees AJ, Blackburn NA, Campbell VL The nighttime problems of Parkinson's disease. Clin Neuropharmacol 1988, 11:512-519.
39. Currie LJ, Bennett JP, Harrison MB, et al. Clinical correlates of sleep benefit in Parkinson's disease. Neurology 1997, 48:1115-1117.
40. Bateman DE, Levett K, Marsden CD Sleep benefit in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999, 67:384-385.
41. Hogl BE, Gomez-Arevalo G, Garcia S, et al. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology 1998, 50:1332-1339.
42. Yamamura Y, Sobue I, Ando K, et al. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 1973, 23:239-244.
43. American Sleep Disorders Association International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual 1997, American Sleep Disorders Association, Rochester, Minn.
44. Olson EJ, Boeve BF, Silber MH Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases. Brain 2000, 123:331-339.
45. Comella CL, Nardine TM, Diederich NJ, et al. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 1998, 51:526-529.
46. Gagnon JF, Bedard MA, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002, 59:585-589.
47. Eisensehr I, Lindeiner H, Jäger M, et al. REM sleep behavior disorder in sleep-disordered patients with versus without Parkinson's disease: Is there a need for polysomnography?. J Neurol Sci 2001, 186:7-11.
48. Plazzi G, Cortelli P, Montagna P, et al. REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure. J Neurol Neurosurg Psychiatry 1998, 64:683-685.
49. Eisensehr I, Linke R, Noachtar S, et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behavior disorder: Comparison with Parkinson's disease and controls. Brain 2000, 123:1155-1160.
50. Arnulf I, Bonnet AM, Damier P, et al. Hallucinations, REM sleep, and Parkinson's disease: A medical hypothesis. Neurology 2000, 55:281-288.
51. Henderson JM, Lu Y, Wang S, et al. Olfactory deficits and sleep disturbances in Parkinson's disease: A case-control survey. J Neurol Neurosurg Psychiatry 2003, 74:956-958.
52. Hovestadt A, Bogaard JM, Meerwaldt JD, et al. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989, 52:329-333.
53. Vincken WG, Gauthier SG, Dollfuss RE, et al. Involvement of upper-airway muscles in extrapyramidal disorders: A cause of airflow limitation. N Engl J Med 1984, 311:438-442.
54. Hardie RJ, Efthimiou J, Stern GM Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry 1986, 49:1326.
55. Apps MCP, SheaffPC, Ingram DA, et al. Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry 1985, 48:1240-1245.
56. Chokroverty S, Sharp JT, Barron KD Periodic respiration in erect posture in Shy-Drager syndrome. J Neurol Neurosurg Psychiatry 1978, 41:980-986.
57. McNicholas WT, Rutherford R, Grossman R, et al. Abnormal respiratory pattern generation during sleep in patients with autonomic dysfunction. Am Rev Respir Dis 1983, 128:429-433.
58. Guilleminault C, Briskin JG, Greenfield MS, et al. The impact of autonomic nervous system dysfunction on breathing during sleep. Sleep 1981, 4:263-268.
59. Kenyon GS, Apps MCP, Traub M Stridor and obstructive sleep apnea in Shy-Drager syndrome treated by laryngofissure and cord lateralization. Laryngoscope 1984, 94:1106-1108.
60. Isozaki E, Naito A, Horiguchi S, et al. Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996, 60:399-402.
61. Guilleminault C, Tilkian A, Lehrman K, et al. Sleep apnoea syndrome: States of sleep and autonomic dysfunction. J Neurol Neurosurg Psychiatry 1977, 40:718-725.
62. Frucht S, Rogers JD, Greene PE, et al. Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999, 52:1908-1910.
63. Ondo WG, Dat Vuong K, Khan H, et al. Daytime sleepiness and other sleep disorders in Parkinson's disease. Neurology 2001, 57:1392-1396.
64. Brodsky MA, Godbold J, Roth T, et al. Sleepiness in Parkinson's disease: A controlled study. Mov Disord 2003, 18:668-672.
65. Arnulf I, Konofal E, Merino-Andreu M, et al. Parkinson's disease and sleepiness: An integral part of PD. Neurology 2002, 58:1019-1024.
66. Rye D Sleepiness and unintended sleep in Parkinson's disease. Curr Treat Options Neurol 2003, 5:231-239.
67. Merino-Andreu M, Arnulf I, Konofal E, et al. Unawareness of naps in Parkinson's disease and in disorders with excessive daytime sleepiness. Neurology 2003, 60:1553-1554.
68. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson's Disease Sleep Scale: A new instrument for assessing sleep and nocturnal disability in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002, 73:629-633.
69. Leeman AL, ONeill CJ, Nicholson PW, et al. Parkinson's disease in the elderly: Response to and an optimal spacing of night time dosing with levodopa. Br J Clin Pharmacol 1987, 24:637-643.
70. Monti JM, Hawkins M, Jantos H, et al. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat. Psychopharmacology 1988, 95:395-400.
71. Cantor CR, Stern MB Dopamine agonists and sleep in Parkinson's disease. Neurology 2002, 58:S71-S78.
72. Askenasy JJ, Yahr MD Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: A preliminary study. Neurology 1985, 35:527-532.
73. Jansen EN, Meerwaldtt JD Madopar HBS in nocturnal symptoms of Parkinson's disease. Adv Neurol 1990, 53:527-531.
74. Koller WC, Hutton JT, Tolosa E, et al. Immediate-release and controlled-release carbidopa/levodopa in PD: A 5-year randomized multicenter study. Carbidopa/Levodopa Study Group. Neurology 1999, 53:1012-1019.
75. Hogl B, Rothdach A, Wetter TC, et al. The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease. Neuropsychopharmacology 2003, 28:1866-1870.
76. Lang AE, Quinn N, Brincat S, et al. Pergolide in late-stage Parkinson disease. Ann Neurol 1982, 12:243-247.
77. Klawans HL, Goetz C, Bergan D Levodopa-induced myoclonus. Arch Neurol 1975, 32:331-334.
78. Vardi J, Glaubman H, Rabey J, et al. EEG sleep patterns in Parkinsonian patients treated with bromocriptine and L-dopa: A comparative study. J Neural Transm 1979, 45:307-316.
79. Schenck C, Mahowald M A polysomnographic, neurologic, psychiatric and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89% of 57 treated patients. Cleve Clin J Med 1990, 57:10-24.
80. Gordon PH, Pullman SL, Louis ED, et al. Mirtazapine in parkinsonian tremor. Parkinsonism Relat Disord 2002, 9:125-126.
81. Scharf B, Moskovitz C, Lupton MD, et al. Dream phenomena induced by chronic levodopa therapy. J Neural Transm 1978, 43:143-151.
82. The Parkinson Study Group Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 1999, 340:757-763.
83. Fernandez HH, Friedman JH, Jacques C, et al. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease. Mov Disord 1999, 14:484-487.
84. Reddy S, Factor SA, Molho ES, et al. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia. Mov Disord 2002, 17:676-681.
85. Braga-Neto P, Pereira da Silva-Junior F, Sueli Monte F, et al. Snoring and excessive daytime sleepiness in Parkinson's disease. J Neurol Sci 2004, 217:41-45.
86. Dale RC, Church AJ, Surtees RA, et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 2004, 127:21-33.
87. Hauser RA, Wahba MN, Zesiewicz TA, McDowell Anderson W Modafinil treatment of pramipexole-associated somnolence. Mov Disord 2000, 15:1269-1271.
88. Hogl B, Saletu M, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: A double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002, 25:905-909.
89. Adler CH, Caviness JN, Hentz JG, et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord 2003, 18:287-293.